The Essure Procedure.
The Essure Procedure is an IN OFFICE
TUBAL OCCLUSION (WITH NO ABDOMINAL INCISION!!)
In November 2002, the FDA granted approval
to the Essure Permanent Birth Control
device, a small metallic implant placed
into the fallopian tubes through hysteroscopic
guidance.
The device requires use of alternate
contraception for a 3-month waiting period
after insertion and radiologic confirmation
of tubal occlusion.
Most common side effects were cramping
in 20% and nausea/vomiting in 8% of women
(during placement); more serious side
effects included expulsion (2.2%) and
uterine perforation (1.5%).
Advantages include lower cost and avoidance
of abdominal scar.
|
